Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Language
Publication year range
1.
Am J Vet Res ; 84(10): 1-6, 2023 Sep 01.
Article in English | MEDLINE | ID: mdl-37586694

ABSTRACT

OBJECTIVE: Compare erythropoiesis-related factors between different stages of canine chronic kidney disease (CKD). ANIMALS: 8 healthy adult dogs (controls), and 24 dogs with CKD, equally divided into 3 groups based on International Renal Interest Society-CKD Guidelines (stage 2, 3, and 4) were recruited between December 2012 and December 2014. METHODS: The following were assessed in all dogs and then compared between groups: bone marrow cytology, CBC, reticulocyte count, urinalysis, serum biochemistry, blood pressure, occult gastrointestinal bleeding, and serum concentrations of parathyroid hormone (PTH), erythropoietin, interleukin-1ß, interleukin-3, tumor necrosis factor-α (TNFα), and interferon-γ. RESULTS: Erythropoiesis inducing and suppressing factors and the results of the bone marrow cytology of dogs in stage 2 CKD did not differ from the control group. The presence of reticulocytosis in CKD stage 2 suggests that blood loss or erythrocyte destruction might be contributing to developing anemia. Anemia in dogs with progressive CKD was associated with increasing PTH and TNFα and with elevation of the ratio of myeloid to erythroid precursor cells caused by hypoplasia of the erythroid series. The latter was represented mainly by a decrease in the population of polychromatophilic rubricytes and metarubricytes. CLINICAL RELEVANCE: Increased PTH and TNFα seem to contribute to the reduced percentage of polychromatophilic rubricytes and erythroid population, thereby aggravating the anemia of dogs with advanced CKD. Gastrointestinal blood loss contributes to anemia in all canine CKD stages.


Subject(s)
Anemia , Dog Diseases , Renal Insufficiency, Chronic , Dogs , Animals , Erythroid Precursor Cells , Tumor Necrosis Factor-alpha , Anemia/etiology , Anemia/veterinary , Renal Insufficiency, Chronic/complications , Renal Insufficiency, Chronic/veterinary , Inflammation/complications , Inflammation/veterinary , Gastrointestinal Hemorrhage/complications , Gastrointestinal Hemorrhage/veterinary
2.
Domest Anim Endocrinol ; 76: 106610, 2021 07.
Article in English | MEDLINE | ID: mdl-33607308

ABSTRACT

Hyperlipidemia is described as an increase in serum and/or plasma levels of triglycerides, cholesterol, or both. This disturbance can be primary in some cases, or combined with other comorbidities such as endocrinopathies, liver diseases, or specific drug use. Among the various ways to control dyslipidemia are specific diets, omega-3 fatty acid supplementation, or hypolipemiant treatment. Herbal medicine has been used in the human clinical routine to reduce cholesterol circulation. With an aim to expand its application in veterinary medicine, we analyzed the use of phytosterols in dogs as a potential alternative to control hypercholesterolemia. We performed lipidogram analysis in healthy dogs to examine the possible adverse effects during the treatment. Eight Beagle dogs received orally two 650 mg capsules of phytosterols (Collestra, Aché), for 15 consecutive d, along with the 2 usual meals. All animals remained clinically stable during the trial. There were significant alterations in low-density lipoprotein (LDL) and high-density lipoprotein (HDL) levels during the trial. LDL was reduced (86.8 ± 29.89 mg/dL [D0], 74.45 ± 31.58 mg/dL [D8], and 58.91 ± 18.65 mg/dL [D15]; P = 0.0442) and HDL was elevated (83.40 ± 12.05 mg/dL [D0], 86.46 ± 13.05 mg/dL [D8], and 101.5 ± 10.52 [D15]; P = 0.0141), while total cholesterol and triglyceride concentrations remained constant and within the normal range for canine species. Thus, a 1300 mg dose of phytosterols, administrated orally and fractionated along with the 2 usual meals, was capable of reducing LDL and increasing HDL concentration in healthy nondyslipidemic dogs, which makes them candidates to be included on the list of hypolipemiant drugs for clinical use in dogs with hypercholesterolemia.


Subject(s)
Dog Diseases , Hypercholesterolemia , Phytosterols , Animals , Cholesterol , Cholesterol, LDL/therapeutic use , Dog Diseases/drug therapy , Dogs , Hypercholesterolemia/drug therapy , Hypercholesterolemia/veterinary , Phytosterols/therapeutic use , Triglycerides/therapeutic use
3.
Int J Sports Physiol Perform ; 14(5): 658-664, 2019 May 01.
Article in English | MEDLINE | ID: mdl-30427226

ABSTRACT

Synchronized swimming is a sport that requires high levels of strength, power, and endurance, as well as artistic skill to perform in an aquatic environment. Purpose: The purpose of this study was to identify physiological characteristics and dietary habits of collegiate synchronized swimmers. Methods: A total of 21 female participants (mean [SD] age = 20.4 [1.6] y, height = 168.0 [4.9] cm, and weight = 64.4 [8.7] kg) performed resting metabolic rate test. Body composition was determined using skinfolds (4-site and 7-site) and dual-energy X-ray absorptiometry (DEXA). Dietary intake was assessed using 4-d dietary records. Results: Resting metabolic rate was 110.9 (10.5) kJ/kg normalized to body weight and calculated relative daily caloric intake was 121.4 (42.3) kJ/kg. Estimated energy availability ranged from 109.1 (52.1) to 126.7 (52.6) kJ/kg fat-free mass per day and was correlated (P = .045) to resting metabolic rate. Percentage body fat measured using DEXA (28.7% [4.8%] fat) was higher than both 4-site (25.7% [4.8%] fat, P = .001) and 7-site (25.3% [4.7%] fat, P = .001) skinfold values. No significant correlations were reported between bone mineral density, body composition, and dietary intake data. Conclusions: Synchronized swimmers have similar body composition and training habits as other competitive aquatic athletes. Dietary intake data revealed low energy availability and lower than recommended macronutrient levels.


Subject(s)
Basal Metabolism , Body Composition , Swimming/physiology , Absorptiometry, Photon , Athletes , Body Weight , Bone Density , Diet , Energy Intake , Female , Humans , Nutritional Status , Young Adult
4.
Pesqui. vet. bras ; 38(10): 1949-1954, out. 2018. tab
Article in English | LILACS, VETINDEX | ID: biblio-976372

ABSTRACT

In view of the fact that cancer is considered a chronic disease that can interfere with hormonal homeostasis by means of cytokines, we hypothesized that, even at early stages, mammary carcinoma is able to alter the balance of the hypothalamic-pituitary-thyroid and hypothalamic-pituitary-adrenal axes. To test this hypothesis, the serum concentrations of basal cortisol, thyroxine (T4), free thyroxine (fT4), and thyroid-stimulating hormone (TSH) were evaluated in 20 unspayed bitches that had a histopathological diagnosis of grade 1 mammary carcinoma at clinical stage I according to the World Health Organization (WHO) classification (T1N0M0). The control animals comprised 10 unspayed bitches in perfect health conditions that were matched with those with mammary carcinoma by age. No significant differences regarding the concentrations of basal cortisol, TSH, t4, and fT4 were found between the bitches carrying early stage mammary carcinoma when compared to the control group. This suggests that, even if malignant, early-stage mammary carcinomas do not exhibit the ability to alter the concentrations of hormones produced by the hypothalamic-pituitary-adrenal or hypothalamic-pituitary-thyroid axes.(AU)


Em vista do fato de neoplasias serem consideradas doenças crônicas que por meio de citocinas podem interferir na homeostase hormonal, hipotetizou-se que o carcinoma mamário, mesmo nos seus estádios iniciais, fosse capaz de alterar o equilíbrio dos eixos hipotalâmico-hipofisário-tireóideo e hipotalâmico-hipofisário-adrenal. Para tal, foram avaliadas as concentrações séricas de cortisol basal, tiroxina (T4), tiroxina livre (fT4) e tireotrofina (TSH) de 20 fêmeas caninas, inteiras, com diagnóstico histopatológico de carcinoma mamário grau 1 e estadiamento clínico I segundo a classificação da Organização Mundial da Saúde - OMS (T1N0M0). Os animais controle constituíram-se por 10 fêmeas caninas inteiras, em perfeitas condições de higidez, as quais foram pareadas, por idade, com aquelas portadoras de carcinoma mamário. Não foram encontradas diferenças significativas nas concentrações de cortisol basal, TSH, T4 e fT4 das cadelas portadoras de carcinoma mamário em estádio inicial quando comparadas às controles sugerindo que, mesmo considerados malignos, ainda não apresentam a capacidade de alterar as concentrações dos hormônios produzidos pelos eixos hipotalâmico-hipofisário-adrenal e tireóideo.(AU)


Subject(s)
Animals , Dogs , Pituitary-Adrenal System , Mammary Neoplasms, Animal/diagnosis , Dogs/blood , Hypothalamo-Hypophyseal System
SELECTION OF CITATIONS
SEARCH DETAIL
...